Skip to Main Content
TRC_PL_NEW
Menu
    • Products
      • Hospital Pharmacist's Letter
      • Hospital Pharmacy Technician's Letter
      • Learning Management Portal
      • NatMed Advisor
      • NatMed Pro
      • Pharmacist's Letter
      • Pharmacist's Letter Canada
      • Pharmacy Technician's Letter
      • Pharmacy Technician's Letter Canada
      • Prescriber's Letter
      • RxAdvanced
      • RxSelect

    Subscribe Login
  • Home
  • Letter
    • Current Issue
    • Past Issues
    • Suggest a Topic
  • Browse
    • Subject
    • Charts
    • COVID-19 Resources
    • Diabetes Resources
    • Immunization Resources
    • Natural Medicines Resources
    • Journal Club
  • Podcasts
  • Drug Charts
    • Antidepressants
    • Contraceptives
    • Diabetes Drugs
    • Do Not Crush List
    • First Time Generics
    • New Drugs
    • More Charts >
  • Help
    • User Support
    • Contact Us
  • Go To CE/CME & Training

Upgrade Your Browser

We no longer support this version of your browser. We recommend that you upgrade to the latest version of Internet Explorer, Firefox, Chrome or Safari to improve your security and experience using this website.

Return to the course you were viewing

New! RxAdvanced: Diabetes Monitoring & Management program provides pharmacists with the skills needed to effectively advise patients and clinicians on how to use technology and pattern management to achieve improved glycemic control. Learn More.
  1. Home
  2. Browse
  3. Interactions
  4. Cardiology
  5. Antiplatelets/Anticoagulants
  6. Rivaroxaban

Rivaroxaban

  • Bone & Joint (72)
  • Cardiology (294)
    • Antiarrhythmics (80)
    • Antihypertensives (92)
    • Antiplatelets/Anticoagulants (150)
      • Apixaban (15)
      • Aspirin (36)
      • Clopidogrel (43)
      • Dabigatran (21)
      • Edoxaban (10)
      • Rivaroxaban (12)
      • Ticagrelor (10)
      • Vorapaxar (4)
      • Warfarin (100)
    • Dyslipidemia Drugs (73)
    • Other (23)
  • Dermatology (61)
  • Diabetes & Endocrinology (44)
  • Gastroenterology (86)
  • Hematology & Oncology (9)
  • Infectious Diseases (254)
  • Men's Health (6)
  • Natural Medicines / Supplements / Food Interactions (148)
  • Neurology (153)
  • Nutrition & Obesity (13)
  • Psychiatry (163)
  • Resources (41)
  • Respiratory & Allergy (30)
  • Transplant Meds (14)
  • Women's Health (53)
1 - 12 of 12 Results
Sort Results:
  • Title: Ascending (A-Z)
  • Date: Newest First
  • Date: Oldest First
Article: Know Which DOAC Interactions Require a Med Change May 2023
Chart: Comparison of Oral Anticoagulants March 2023
Technician Tutorial: Dispensing Oral Blood Thinners November 2022
Article: Help Ensure Appropriate DOAC Dosing August 2022
Article: Expect to See DOACs for Venous Thromboembolism Due to Cancer June 2020
Chart: P-glycoprotein Drug Interactions June 2020
Chart: Cytochrome P450 (CYP) Drug Interactions June 2020
Article: Consider It a Red Flag if You See a Direct Oral Anticoagulant Plus Warfarin February 2019
Chart: Bridging Warfarin February 2019
Article: Explain Risks and Benefits of Medical Marijuana September 2017
Article: Watch for Direct Oral Anticoagulant (Pradaxa, etc) Drug Interactions May 2016
PL Voices: Managing Interactions With Direct Oral Anticoagulants (DOACs) May 2016
  • 1
  • About Us
  • Our Mission
  • Our Team
  • Testimonials
  • Careers
  • Newsroom
  • Products
  • Pharmacist Solutions
  • Prescriber Solutions
  • Hospital Solutions
  • Retail Solutions
  • Group Practice Solutions
  • Support & Policies
  • Contact Us
  • Access Agreement
  • Privacy Policy

The contents of this website are not intended to be a substitute for professional medical advice, diagnosis, or treatment. See additional information.

© Therapeutic Research Center. All Rights Reserved